Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.
01 1NURAY CHEMICALS PRIVATE LIMITED
02 1ALMON HEALTHCARE PRIVATE LIMITED
03 1Amoli Organics (A Division of Umedica Laboratories Pvt.Ltd.)
04 7Archimica S.p.A.
05 1Aurore Pharmaceuticals Private Limited
06 1Bajaj healthcare Ltd
07 1CTX Lifesciences Pvt. Ltd.
08 1Dasami Lab Private Limited
09 6F.I.S. FABBRICA ITALIANA SINTETICI S.P.A.
10 1Glenmark Life Sciences Limited
11 1HOSTER LABS PRIVATE LIMITED
12 1Hubei Gedian Humanwell Pharmaceutical Co.,Ltd
13 1Hubei Gedian humanwell Pharmaceutical Co., Ltd
14 2Jubilant Pharmova Limited
15 1Lianhe Chemical Technology Co.,Ltd.
16 1MSN Life Sciences Private Limited
17 1STHREE CHEMICALS PRIVATE LIMITED
01 7OXCARBAZEPINE
02 19Oxcarbazepine
03 1Oxcarbazepine Co-Precipitate
04 2oxcarbazepine
01 3China
02 9India
03 13Italy
04 4Blank
Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.
NDC Package Code : 58159-088
Start Marketing Date : 2021-10-19
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (35kg/35kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 42419-006
Start Marketing Date : 2009-01-27
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 48087-0046
Start Marketing Date : 2012-12-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 48087-0114
Start Marketing Date : 2014-07-16
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 48087-0115
Start Marketing Date : 2015-04-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 48087-0118
Start Marketing Date : 2015-03-10
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 48087-0157
Start Marketing Date : 2021-01-29
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 48087-0158
Start Marketing Date : 2021-01-29
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51508-008
Start Marketing Date : 2019-07-17
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51508-205
Start Marketing Date : 2024-11-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
36
PharmaCompass offers a list of Oxcarbazepine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Oxcarbazepine manufacturer or Oxcarbazepine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Oxcarbazepine manufacturer or Oxcarbazepine supplier.
PharmaCompass also assists you with knowing the Oxcarbazepine API Price utilized in the formulation of products. Oxcarbazepine API Price is not always fixed or binding as the Oxcarbazepine Price is obtained through a variety of data sources. The Oxcarbazepine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 5-oxo-6H-benzo[b][1]benzazepine-11-carboxamide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 5-oxo-6H-benzo[b][1]benzazepine-11-carboxamide, including repackagers and relabelers. The FDA regulates 5-oxo-6H-benzo[b][1]benzazepine-11-carboxamide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 5-oxo-6H-benzo[b][1]benzazepine-11-carboxamide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of 5-oxo-6H-benzo[b][1]benzazepine-11-carboxamide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A 5-oxo-6H-benzo[b][1]benzazepine-11-carboxamide supplier is an individual or a company that provides 5-oxo-6H-benzo[b][1]benzazepine-11-carboxamide active pharmaceutical ingredient (API) or 5-oxo-6H-benzo[b][1]benzazepine-11-carboxamide finished formulations upon request. The 5-oxo-6H-benzo[b][1]benzazepine-11-carboxamide suppliers may include 5-oxo-6H-benzo[b][1]benzazepine-11-carboxamide API manufacturers, exporters, distributors and traders.
click here to find a list of 5-oxo-6H-benzo[b][1]benzazepine-11-carboxamide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing 5-oxo-6H-benzo[b][1]benzazepine-11-carboxamide as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for 5-oxo-6H-benzo[b][1]benzazepine-11-carboxamide API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture 5-oxo-6H-benzo[b][1]benzazepine-11-carboxamide as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain 5-oxo-6H-benzo[b][1]benzazepine-11-carboxamide and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a 5-oxo-6H-benzo[b][1]benzazepine-11-carboxamide NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of 5-oxo-6H-benzo[b][1]benzazepine-11-carboxamide suppliers with NDC on PharmaCompass.
We have 12 companies offering 5-oxo-6H-benzo[b][1]benzazepine-11-carboxamide
Get in contact with the supplier of your choice:
